HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yixin Zhong Selected Research

perflubron (L 1913)

1/2021Combination Nanotherapeutics for Dry Eye Disease Treatment in a Rabbit Model.
1/2019NIR-responsive nanoplatform for pre/intraoperative image-guided carcinoma surgery and photothermal ablation of residual tumor tissue.
8/2018Mitochondria-Targeted Artificial "Nano-RBCs" for Amplified Synergistic Cancer Phototherapy by a Single NIR Irradiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yixin Zhong Research Topics

Disease

6Neoplasms (Cancer)
03/2022 - 08/2018
5Thrombosis (Thrombus)
04/2022 - 12/2017
2Neoplasm Metastasis (Metastasis)
02/2022 - 09/2021
2Breast Neoplasms (Breast Cancer)
02/2022 - 01/2019
1Hemorrhage
04/2022
1Vascular Tissue Neoplasms
10/2021
1Hyperthermia
10/2021
1Hypoxia (Hypoxemia)
09/2021
1Dry Eye Syndromes (Dry Eye Syndrome)
01/2021
1Inflammation (Inflammations)
01/2021
1Atherosclerotic Plaque (Atheroma)
03/2019
1Residual Neoplasm
01/2019
1Body Weight (Weight, Body)
04/2014
1Coronary Disease (Coronary Heart Disease)
04/2014
1Parkinson Disease (Parkinson's Disease)
04/2014
1Stroke (Strokes)
04/2014
1Hypertension (High Blood Pressure)
04/2014
1Orthostatic Hypotension (Postural Hypotension)
04/2014

Drug/Important Bio-Agent (IBA)

3Oxygen (Dioxygen)IBA
03/2022 - 08/2018
3perflubron (L 1913)FDA Link
01/2021 - 08/2018
2FibrinIBA
04/2022 - 01/2019
2Glutathione (Reduced Glutathione)IBA
03/2022 - 09/2021
2cysteinyl-arginyl-glutamyl-lysyl-alanylIBA
01/2022 - 01/2019
2Liposomes (Liposome)IBA
01/2021 - 01/2019
1Ketotifen (Ketotifene)FDA Link
04/2022
1Free RadicalsIBA
03/2022
1IronIBA
03/2022
1Immune Checkpoint InhibitorsIBA
02/2022
1ferric oxide (iron oxide)IBA
02/2022
1hematoporphyrin monomethyl etherIBA
02/2022
1mahuang-tangIBA
10/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2021
1Therapeutic UsesIBA
09/2021
1tetrandrineIBA
01/2021
1CytokinesIBA
01/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021
1ApolipoproteinsIBA
03/2019
1Apolipoproteins E (ApoE)IBA
03/2019
1CholesterolIBA
03/2019
1Coloring Agents (Dyes)IBA
01/2019
1IntegrinsIBA
01/2019
1LigandsIBA
01/2019
1polydopamineIBA
01/2019
1P-SelectinIBA
01/2019
1Peptides (Polypeptides)IBA
01/2019
1IodidesIBA
01/2019
1Indicators and Reagents (Reagents)IBA
01/2019
11-phenyl-3,3-dimethyltriazene (PDT)IBA
08/2018
1Contrast MediaIBA
12/2017
1Antihypertensive Agents (Antihypertensives)IBA
04/2014
1hydroxide ionIBA
04/2014

Therapy/Procedure

5Therapeutics
03/2022 - 01/2021
3Precision Medicine
03/2022 - 12/2017
2Photothermal Therapy
01/2019 - 08/2018
1Immunotherapy
02/2022
1Photochemotherapy (Photodynamic Therapy)
08/2018
1Phototherapy (Light Therapy)
08/2018